arrow
P

Paul Zarogoulidis

general clinic of thessaloniki
H指数:64
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multiomics and experimental validation reveal theophylline’s mechanism targeting IL1A/ACTB/TLR4 and identify synergistic drugs in hepatocellular carcinoma

多组学和实验验证揭示了茶碱靶向IL1A/ACTB/TLR4的机制,并鉴定出肝细胞癌中的协同药物

2026-02-100
PRE
Vessel sign analysis paves the way to optimized CBCT application in interventional pulmonology: COMBINED algorithm as a one-stop-shop

血管征象分析为介入肺脏病学中优化CBCT应用铺平了道路:COMBINED算法作为一站式解决方案

2025-03-210
OA
Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy

用于癌症免疫治疗的免疫特异性和肿瘤依赖性mRNA疫苗: 将临床翻译重编程为肿瘤编辑治疗

2024-03-252
OAAI
Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization

肿瘤细胞代谢重编程和缺氧免疫抑制: 驱使癌发生转移定植

2024-01-165
OAAI
Nebulisation of Paclitaxel, Sotatercept and Iloprost for pulmonary hypertension for lung cancer. From In vitro to In vivo
2024-01-010
OAAI
Revisiting Temozolomide's role in solid tumors: Old is gold?

重温替莫唑胺在实体瘤中的作用: 古老是金?

2024-01-011
OAAI
Ablation for Single Pulmonary Nodules, Primary or Metastatic. Εndobronchial Ablation Systems or Percutaneous
2024-01-012
OAAI
Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery

通过嵌合抗原受体-T细胞疗法进行免疫工程: 重编程纳米药物递送

2023-10-131
OAAI
Endobronchial Radiofrequency Ablation for pulmonary nodules with Radial-Ebus and Navigation: Pros and Cons
2023-01-017
OAAI
Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8+T Cell Immunity

工程化杂交Treg靶向纳米体通过诱导肿瘤内CD8 T细胞免疫抑制肺免疫抑制

2022-09-015
OAAI